Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Paronychia treatment Companies

ID: MRFR/Pharma/1184-HCR
80 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Companies specifically dedicated to paronychia treatment may not be widespread, as this condition is typically managed by healthcare professionals using a combination of general wound care and, in some cases, prescription medications. However, companies producing relevant pharmaceuticals or products for wound care and infection management may be involved
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Paronychia treatment Market

Paronychia Treatment Market
ย 

Latestย Paronychia Treatmentย Companiesย Updates:

Bausch Health expands Jublia reach: In October 2023, Jublia, their topical solution for paronychia, received marketing authorization in Canada, expanding its availability beyond the US and Europe.

Moberg Pharma strengthens MEA presence: Their agreement with Mundipharma in November 2020 grants them wider distribution of their topical nail disorder treatments throughout the Middle East and Africa.

FDA approval for dabrafenib/trametinib: In June 2022, the FDA approved this combination therapy for treating a rare form of paronychia related to BRAF gene mutations, offering hope for patients with limited treatment options.

List ofย Paronychia treatmentย Key companies in the market:

  • GlaxoSmithKline plc
  • Perrigo New York, Inc.
  • Jonakayem Pharma Formulation Pvt. Ltd.
  • Glenmark Generics Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Fougera Pharmaceuticals Inc.
  • Eli Lilly Company